Literature DB >> 22489704

Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery.

Zohreh Amoozgar1, Joonyoung Park, Qingnuo Lin, Yoon Yeo.   

Abstract

When a nanoparticle is developed for systemic application, its surface is typically protected by poly(ethylene glycol) (PEG) to help prolonged circulation and evasion of immune clearance. On the other hand, PEG can interfere with interactions between nanocarriers and target cells and negatively influence the therapeutic outcomes. To overcome this challenge, we propose low molecular-weight chitosan (LMWC) as an alternative surface coating, which can protect the nanomedicine in neutral pH but allow cellular interactions in the weakly acidic pH of tumors. LMWCs with a molecular weight of 2-4 kDa, 4-6.5 kDa, and 11-22 kDa were produced by hydrogen peroxide digestion and covalently conjugated with poly(lactic-co-glycolic acid) (PLGA). Nanoparticles created with PLGA-LMWC conjugates showed pH-sensitive cell interactions, which enabled specific drug delivery to cells in a weakly acidic environment. The hydrophilic LMWC layer reduced opsonization and phagocytic uptake. These properties qualify LMWCs as a promising biomaterial for pH-sensitive stealth coating.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22489704      PMCID: PMC3355976          DOI: 10.1021/mp2005615

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  25 in total

Review 1.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Authors:  Donald E Owens; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2005-11-21       Impact factor: 5.875

2.  Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice.

Authors:  Daniel Moreno; Sara Zalba; Iñigo Navarro; Conchita Tros de Ilarduya; María J Garrido
Journal:  Eur J Pharm Biopharm       Date:  2009-10-31       Impact factor: 5.571

Review 3.  PEGylated nanoparticles for biological and pharmaceutical applications.

Authors:  Hidenori Otsuka; Yukio Nagasaki; Kazunori Kataoka
Journal:  Adv Drug Deliv Rev       Date:  2003-02-24       Impact factor: 15.470

4.  Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?

Authors:  R L Hong; C J Huang; Y L Tseng; V F Pang; S T Chen; J J Liu; F H Chang
Journal:  Clin Cancer Res       Date:  1999-11       Impact factor: 12.531

5.  Layer by layer chitosan/alginate coatings on poly(lactide-co-glycolide) nanoparticles for antifouling protection and Folic acid binding to achieve selective cell targeting.

Authors:  Jie Zhou; Gabriela Romero; Elena Rojas; Lie Ma; Sergio Moya; Changyou Gao
Journal:  J Colloid Interface Sci       Date:  2010-02-12       Impact factor: 8.128

6.  Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.

Authors:  Christoph Mamot; Daryl C Drummond; Charles O Noble; Verena Kallab; Zexiong Guo; Keelung Hong; Dmitri B Kirpotin; John W Park
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

7.  Acid pH in tumors and its potential for therapeutic exploitation.

Authors:  I F Tannock; D Rotin
Journal:  Cancer Res       Date:  1989-08-15       Impact factor: 12.701

8.  "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

Authors:  R M Sawant; J P Hurley; S Salmaso; A Kale; E Tolcheva; T S Levchenko; V P Torchilin
Journal:  Bioconjug Chem       Date:  2006 Jul-Aug       Impact factor: 4.774

9.  Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake.

Authors:  H Carrstensen; R H Müller; B W Müller
Journal:  Clin Nutr       Date:  1992-10       Impact factor: 7.324

10.  PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles.

Authors:  Swaroop Mishra; Paul Webster; Mark E Davis
Journal:  Eur J Cell Biol       Date:  2004-04       Impact factor: 4.492

View more
  31 in total

Review 1.  Extracellularly activatable nanocarriers for drug delivery to tumors.

Authors:  Sara A Abouelmagd; Hyesun Hyun; Yoon Yeo
Journal:  Expert Opin Drug Deliv       Date:  2014-06-20       Impact factor: 6.648

2.  Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.

Authors:  Sathish Dyawanapelly; Uday Koli; Vimisha Dharamdasani; Ratnesh Jain; Prajakta Dandekar
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

3.  Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin.

Authors:  Tianzhi Yang; Divine Nyiawung; Alexandra Silber; Jiukuan Hao; Leanne Lai; Shuhua Bai
Journal:  AAPS PharmSciTech       Date:  2012-09-28       Impact factor: 3.246

4.  Tannic acid-mediated surface functionalization of polymeric nanoparticles.

Authors:  Sara A Abouelmagd; Fanfei Meng; Bieong-Kil Kim; Hyesun Hyun; Yoon Yeo
Journal:  ACS Biomater Sci Eng       Date:  2016-10-27

5.  Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals.

Authors:  Bo Sun; Maie S Taha; Benjamin Ramsey; Sandra Torregrosa-Allen; Bennett D Elzey; Yoon Yeo
Journal:  J Control Release       Date:  2016-05-26       Impact factor: 9.776

Review 6.  Application of polysaccharides for surface modification of nanomedicines.

Authors:  Kyung-Oh Doh; Yoon Yeo
Journal:  Ther Deliv       Date:  2012-12

Review 7.  Extracellular stability of nanoparticulate drug carriers.

Authors:  Karen C Liu; Yoon Yeo
Journal:  Arch Pharm Res       Date:  2013-11-12       Impact factor: 4.946

8.  Synthesis, characterization and anticancer activity of tanshinone I grafted low molecular chitosan.

Authors:  Dongdong Wang; Yuelin Sun; Yuanyuan Wu; Lili Ma; Jinyou Duan
Journal:  Glycoconj J       Date:  2016-09-15       Impact factor: 2.916

9.  Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.

Authors:  Jinho Park; Yihua Pei; Hyesun Hyun; Mark A Castanares; David S Collins; Yoon Yeo
Journal:  J Control Release       Date:  2017-10-27       Impact factor: 9.776

10.  Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles.

Authors:  Emily Gullotti; Joonyoung Park; Yoon Yeo
Journal:  Pharm Res       Date:  2013-04-23       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.